Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid …

Symptomatic Venous Thromboembolism (VTE)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07213778